292 related articles for article (PubMed ID: 29923432)
1. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
De Back TR; Kater AP; Tonino SH
Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
[TBL] [Abstract][Full Text] [Related]
2. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
3. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
Tsang M; Parikh SA
Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.
Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Shtalrid M; Berrebi A; Polliack A;
Ann Hematol; 2013 May; 92(5):661-7. PubMed ID: 23274356
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune cytopenias in chronic lymphocytic leukemia.
Visco C; Barcellini W; Maura F; Neri A; Cortelezzi A; Rodeghiero F
Am J Hematol; 2014 Nov; 89(11):1055-62. PubMed ID: 24912821
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
Diehl LF; Ketchum LH
Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
[TBL] [Abstract][Full Text] [Related]
9. ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients.
Zanotti R; Frattini F; Ghia P; Visco C; Zamò A; Perbellini O; Stella S; Facco M; Giaretta I; Chilosi M; Pizzolo G; Ambrosetti A
Am J Hematol; 2010 Jul; 85(7):494-8. PubMed ID: 20575031
[TBL] [Abstract][Full Text] [Related]
10. Clinical and serological autoimmune complications in chronic lymphocytic leukemia.
Demir C; Ekinci Ö
Wien Klin Wochenschr; 2017 Aug; 129(15-16):552-557. PubMed ID: 28477093
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
Visco C; Cortelezzi A; Moretta F; Falisi E; Maura F; Finotto S; Barcellini W; Ambrosetti A; Neri A; Ruggeri M; Rodeghiero F
Leuk Lymphoma; 2014 Jun; 55(6):1261-5. PubMed ID: 24047107
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune cytopenias in chronic lymphocytic leukemia.
D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.
Tandra P; Krishnamurthy J; Bhatt VR; Newman K; Armitage JO; Akhtari M
Mediterr J Hematol Infect Dis; 2013 Nov; 5(1):e2013068. PubMed ID: 24363883
[TBL] [Abstract][Full Text] [Related]
14. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Wang L; Wu S; Yu G; Sui X; Chu X; Liu X
J Oncol Pharm Pract; 2023 Dec; 29(8):2031-2036. PubMed ID: 37518980
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies.
Albiol N; Moreno C
Cancer J; 2021 Jul-Aug 01; 27(4):286-296. PubMed ID: 34398555
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia.
Atef B; Azmy E; Aladle D; Mabed M
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):97-104. PubMed ID: 30802421
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune complications of chronic lymphocytic leukemia.
Hamblin TJ
Semin Oncol; 2006 Apr; 33(2):230-9. PubMed ID: 16616070
[TBL] [Abstract][Full Text] [Related]
18. Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Michallet AS; Rossignol J; Cazin B; Ysebaert L
Leuk Lymphoma; 2011 Jul; 52(7):1401-3. PubMed ID: 21699387
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
20. Disease-specific complications of chronic lymphocytic leukemia.
Dearden C
Hematology Am Soc Hematol Educ Program; 2008; ():450-6. PubMed ID: 19074125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
